Oncology News

Among patients with negative fecal immunochemical tests, those with values in the upper range demonstrated higher risk for advanced neoplasia vs. those in the lower range, according to data in Annals of Internal Medicine.

A risk-advancement period approach using sex and polygenic risk score helped identify starting ages for colorectal cancer screening, with men reaching an equivalent risk for CRC occurrence and mortality at a younger age than women.

The ColoSense multitarget stool RNA test demonstrated high sensitivity for detection of colorectal cancer and advanced adenoma, notably in individuals aged 45 to 49 years, according to data in JAMA.

Older adults who were given personalized information about benefits and harms of colorectal cancer screening were more likely to receive screening orders that aligned with benefit, reducing overall use of screening, researchers reported.

Glucagon-like peptide 1 receptor agonists were associated with a reduced risk for colorectal cancer among patients with type 2 diabetes, regardless of weight status, compared with other antidiabetics, according to research.

Diagnostic test completion for early age-onset colorectal cancer is low among U.S. veterans presenting with iron-deficiency anemia or hematochezia, with women and Black and Hispanic veterans less likely to undergo follow-up testing.

The cost of liquid biopsy for second-line colorectal cancer screening was not cost-effective and would have to be reduced by 66% to increase uptake among the general population, according to data in JAMA Network Open.

Study findings support performing surveillance colonoscopy 7 to 10 years after detection and polypectomy of baseline non-advanced adenoma rather than at 5 years, researchers wrote in the Journal of Gastroenterology and Hepatology.

Patients with high-risk T1 rectal cancer were at greater risk for recurrence after surgical resection than those with colon cancer, although no significant differences were reported after endoscopic local resection, according to research.

November marks Stomach Cancer Awareness Month, a time to raise awareness about risk factors, prevention and early detection of stomach cancer, which is expected to result in more than 11,000 deaths in 2023.